GLYC - GlycoMimetics Inc
IEX Last Trade
0.1738
0.001 0.345%
Share volume: 572,335
Last Updated: Fri 30 Aug 2024 09:28:01 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.17
0.00
0.35%
Summary score
25%
Profitability
25%
Dept financing
2%
Liquidity
50%
Performance
25%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-9.98%
Return on assets
-9.27%
Return on sales
0%
Return on invested capital
258.11%
Total debt ratio
7.6%
Debt ratio change over timeo
-0.96%
Current Ratio
18.85%
Quick Ratio
0%
Cash Position Ratio
18.56%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-8.08%
Return on assets
-7.71%
Return on sales
0%
Return on invested capital
246.46%
Total debt ratio
7.99%
Debt ratio change over timeo
-0.97%
Current Ratio
15.55%
Quick Ratio
0%
Cash Position Ratio
15.21%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-9.66%
Return on assets
-8.91%
Return on sales
0%
Return on invested capital
299.14%
Total debt ratio
7.96%
Debt ratio change over time
-0.94%
Current Ratio
15.81%
Quick Ratio
0%
Cash Position Ratio
15.45%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-104.78%
Return on assets
-104.4%
Return on sales
0%
Return on invested capital
15.89%
Total debt ratio
-96.42%
Debt ratio change over time
-0.96%
Current Ratio
7.73%
Quick Ratio
0%
Cash Position Ratio
7.59%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | GLYC | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -9.98% | -3.05% | 11.55% | 6.27% |
| Return on assets | -9.27% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 258.11% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 37% | 68% | 59% |
| Total debt ratio | 7.6% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.96% | 6.09% | 6.03% | 1.53% |
| Dept financing | 2% | 50% | 43% | 14% |
| Current Ratio | 15.55% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 15.21% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 13% | 31% | 30% |
| Short-term ratios | GLYC | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -8.08% | -25.62% | 17.94% | 7.14% |
| Return on assets | -7.71% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 246.46% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 39% | 70% | 59% |
| Total debt ratio | 7.99% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.97% | -23.44% | 9.66% | 0.6% |
| Dept financing | 2% | 25% | 45% | 8% |
| Current Ratio | 15.55% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 15.21% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 23% | 19% | 33% |